Narrow search
Showing 1 - 10 of 1,496
Cover Image
The economics of alternative payment models for pharmaceuticals
Hlávka, Jakub P.; Yu, Jeffrey C.; Goldman, Dana P.; … - In: The European journal of health economics 22 (2021) 4, pp. 559-569
Persistent link: https://www.econbiz.de/10012586512
Cover Image
Cheap exclusion in markets with multiple complements
O'Brien, Daniel P.; Israel, Mark; Benton, Erica - In: International journal of industrial organization 89 (2023), pp. 1-16
Persistent link: https://www.econbiz.de/10014546210
Cover Image
Efficient provision of experience goods : evidence from antidepressant choice
Dickstein, Michael J. - 2018 - Latest version: January 23, 2018
Persistent link: https://www.econbiz.de/10011997820
Cover Image
Estimating the heterogeneous welfare effects of choice architecture : an application to the Medicare prescription drug insurance market
Ketcham, Jonathan D.; Kuminoff, Nicolai V.; Powers, … - 2016
Persistent link: https://www.econbiz.de/10011564385
Cover Image
Physician altruism and moral hazard : (no) evidence from finnish national prescriptions data
Crea, Giovanni; Galizzi, Matteo M.; Linnosmaa, Ismo; … - In: Journal of health economics 65 (2019), pp. 153-169
Persistent link: https://www.econbiz.de/10012224598
Cover Image
Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticals
Herr, Annika; Suppliet, Moritz - In: Journal of health economics 56 (2017), pp. 19-29
Persistent link: https://www.econbiz.de/10011798902
Cover Image
Reimbursement of medicine outlays : an optimal insurance approach
Hansen, Bodil O.; Keiding, Hans - 2000
Persistent link: https://www.econbiz.de/10001471495
Cover Image
Can health insurance coverage explain the generic competition paradox?
Ferrara, Ida; Kong, Ying - In: Economics letters 101 (2008) 1, pp. 48-52
Persistent link: https://www.econbiz.de/10003787460
Cover Image
Pharmaceutical cost-sharing systems and savings for health care systems from parallel trade
Birg, Laura - 2013
This paper analyzes the consequences of parallel trade on health care systems in a two-country model with a vertical distributor relationship. In particular, two cost-sharing systems - coinsurance and indemnity insurance - are compared with respect to changes in copayments and public health...
Persistent link: https://www.econbiz.de/10010223102
Cover Image
Do cost-sharing and entry deregulation curb pharmaceutical innovation?
Grossmann, Volker - In: Journal of health economics 32 (2013) 5, pp. 881-894
Persistent link: https://www.econbiz.de/10010210741